Search research articles
Contact Us
Filters
Showing results (71-80 of 172) with videos related to
Page
of 18
Sort By:
Journal of Clinical Psychopharmacology
|
June 10, 2010
Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes
Geoffrey K Isbister, Corrine R Balit, Dawson Macleod, et al.
International Journal of Clinical Pharmacy
|
March 15, 2014
Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand
Ernieda Hatah, June Tordoff, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
September 26, 2006
A Bayesian approach for population pharmacokinetic modelling of sirolimus
Chantaratsamon Dansirikul, Raymond G Morris, Susan E Tett, et al.
British Journal of Clinical Pharmacology
|
December 20, 2020
The propagation of between-subject variability from dose to response
Hesham S Al-Sallami, Daniel F B Wright, Stephen B Duffull
Current Drug Metabolism
|
May 16, 2020
Evaluating Lean Liver Volume as a Potential Scaler for <i>In Vitro-In Vivo</i> Extrapolation of Drug Clearance in Obesity Using the Model Drug Antipyrine
Jaydeep Sinha, Stephen B Duffull, Bruce Green, et al.
Pharmaceutical Research
|
August 9, 2011
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin
Abhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
August 23, 2011
A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose
Finna Shen, Carolyn V Coulter, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology
|
November 18, 2009
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events
Michael A Barras, Stephen B Duffull, John J Atherton, et al.
Therapeutic Drug Monitoring
|
July 2, 2010
Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations
Michael A Barras, Stephen B Duffull, John J Atherton, et al.
Pharmaceutical Research
|
July 2, 2015
Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for Enoxaparin
Abhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 172) with videos related to
Sort By:
Page
of 18
Journal of Clinical Psychopharmacology
|
June 10, 2010
Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes
Geoffrey K Isbister, Corrine R Balit, Dawson Macleod, et al.
International Journal of Clinical Pharmacy
|
March 15, 2014
Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand
Ernieda Hatah, June Tordoff, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
September 26, 2006
A Bayesian approach for population pharmacokinetic modelling of sirolimus
Chantaratsamon Dansirikul, Raymond G Morris, Susan E Tett, et al.
British Journal of Clinical Pharmacology
|
December 20, 2020
The propagation of between-subject variability from dose to response
Hesham S Al-Sallami, Daniel F B Wright, Stephen B Duffull
Current Drug Metabolism
|
May 16, 2020
Evaluating Lean Liver Volume as a Potential Scaler for <i>In Vitro-In Vivo</i> Extrapolation of Drug Clearance in Obesity Using the Model Drug Antipyrine
Jaydeep Sinha, Stephen B Duffull, Bruce Green, et al.
Pharmaceutical Research
|
August 9, 2011
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin
Abhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
August 23, 2011
A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose
Finna Shen, Carolyn V Coulter, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology
|
November 18, 2009
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events
Michael A Barras, Stephen B Duffull, John J Atherton, et al.
Therapeutic Drug Monitoring
|
July 2, 2010
Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations
Michael A Barras, Stephen B Duffull, John J Atherton, et al.
Pharmaceutical Research
|
July 2, 2015
Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for Enoxaparin
Abhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
Page
of 18